Skip to main content

Find Clinical Trials

Home
Conditions
Sezary Syndrome

Clinical trial condition

Sezary Syndrome

Explore clinical trials studying Sezary Syndrome. Study availability and eligibility vary by location and protocol.

262 public trials 17 recruiting studies

Refine in advanced search Browse all conditions

Sezary Syndrome trial results

Completed

MS-275 and Isotretinoin in Treating Patients With Metastatic or Advanced Solid Tumors or Lymphomas

NCT00098891

Conditions: Adult Grade III Lymphomatoid Granulomatosis, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +92 more
Locations: Johns Hopkins University Baltimore, Maryland, United States

View Trial Details

Completed

Genetic Testing Plus Irinotecan in Treating Patients With Solid Tumors or Lymphoma

NCT00003970

Conditions: AIDS-related Peripheral/Systemic Lymphoma, AIDS-related Primary CNS Lymphoma, Anaplastic Large Cell Lymphoma, +99 more
Locations: University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States

View Trial Details

Completed

Cilengitide (EMD 121974) in Treating Patients With Advanced Solid Tumors or Lymphoma

NCT00077155

Conditions: AIDS-related Peripheral/Systemic Lymphoma, AIDS-related Primary CNS Lymphoma, Anaplastic Large Cell Lymphoma, +95 more
Locations: University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States

View Trial Details

Completed

Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment

NCT00008359

Conditions: Adnexal Diseases, Agranulocytosis, Amyloidosis, +141 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

506U78 in Treating Patients With Lymphoma

NCT00005080

Conditions: Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Hematologic Diseases, +32 more
Locations: Cancer and Leukemia Group B Chicago, Illinois, United States

View Trial Details

Completed

Interleukin-2 in Treating Patients With Mycosis Fungoides

NCT00002687

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations: University of Washington Medical Center Seattle, Washington, United States

View Trial Details

Completed

PS-341 in Treating Patients With Advanced Solid Tumors or Lymphoma

NCT00004002

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +43 more
Locations: Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States

Brigham and Women's Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

View Trial Details

Completed

Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer

NCT00255749

Conditions: Amyloidosis, Anemia, Blood Protein Disorders, +64 more
Locations: Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States

View Trial Details

Completed

Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant

NCT00110045

Conditions: Adnexal Diseases, Amyloidosis, Ataxia, +137 more
Locations: CHU Liege - Domaine Universitaire du Sart Tilman Liège, Belgium

Centre Hospitalier Universitaire Henri Mondor Créteil, France

Hopital Edouard Herriot - Lyon Lyon, France

Hopital Saint-Louis Paris, France

View all 13 locations

View Trial Details

Completed

Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients

NCT00003938

Conditions: Adnexal Diseases, Agranulocytosis, Amyloidosis, +147 more
Locations: A.Z. St. Jan Bruges, Belgium

Institut Jules Bordet Brussels, Belgium

Hopital Universitaire Erasme Brussels, Belgium

U.Z. Gasthuisberg Leuven, Belgium

View all 24 locations

View Trial Details